CorVin Clinical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CorVin Clinical
Largest movements
- Cash +€16,885
up €16,885 (+48.3%), from €34,955 to €51,841
mainly Net result for the year (+€70,954) and Other debts (+€15,981)
- Receivables within one year +€1,614
up €1,614 (+4.4%), from €36,884 to €38,498
of which Trade receivables: +€2,256
- Deferred charges and accrued income +€1,610
up €1,610 (+1,477%), from €109 to €1,719
- Profit (loss) carried forward +€20,954
up €20,954 (+98.6%), from €21,252 to €42,206
- Tax, wage and social debts -€16,963
down €16,963 (-81.9%), from €20,717 to €3,754
of which Taxes: -€16,932
- Other debts +€15,981
up €15,981 (+110%), from €14,556 to €30,537
- Trade debts -€935
down €935 (-23.7%), from €3,943 to €3,008
- Gross operating margin +€13,519
up €13,519 (+17.0%), from €79,757 to €93,275
- Taxes +€2,562
up €2,562 (+14.2%), from €18,063 to €20,624
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €72,784 | €92,322 | +€19,538 | +26.8% |
| Fixed assets | 21/28 | €835 | €264 | -€571 | -68.4% |
| Tangible fixed assets | 22/27 | €835 | €264 | -€571 | -68.4% |
| Furniture and vehicles | 24 | €835 | €264 | -€571 | -68.4% |
| Current assets | 29/58 | €71,949 | €92,058 | +€20,110 | +27.9% |
| Amounts receivable within one year | 40/41 | €36,884 | €38,498 | +€1,614 | +4.4% |
| Trade receivables | 40 | €36,242 | €38,498 | +€2,256 | +6.2% |
| Other amounts receivable | 41 | €643 | €0 | -€643 | -100% |
| Cash at bank and in hand | 54/58 | €34,955 | €51,841 | +€16,885 | +48.3% |
| Deferred charges and accrued income | 490/1 | €109 | €1,719 | +€1,610 | +1,477% |
| Total equity and liabilities | 10/49 | €72,784 | €92,322 | +€19,538 | +26.8% |
| Equity | 10/15 | €31,252 | €52,206 | +€20,954 | +67.0% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €21,252 | €42,206 | +€20,954 | +98.6% |
| Amounts payable | 17/49 | €41,532 | €40,116 | -€1,416 | -3.4% |
| Amounts payable within one year | 42/48 | €39,216 | €37,299 | -€1,917 | -4.9% |
| Trade debts | 44 | €3,943 | €3,008 | -€935 | -23.7% |
| Suppliers | 440/4 | €3,943 | €3,008 | -€935 | -23.7% |
| Taxes, remuneration and social security | 45 | €20,717 | €3,754 | -€16,963 | -81.9% |
| Taxes | 450/3 | €18,681 | €1,749 | -€16,932 | -90.6% |
| Remuneration and social security | 454/9 | €2,035 | €2,005 | -€31 | -1.5% |
| Other amounts payable | 47/48 | €14,556 | €30,537 | +€15,981 | +110% |
| Accrued charges and deferred income | 492/3 | €2,316 | €2,817 | +€501 | +21.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €828 | €571 | -€256 | -31.0% |
| Other operating charges | 640/8 | €854 | €939 | +€86 | +10.0% |
| Gross operating margin | 9900 | €79,757 | €93,275 | +€13,519 | +17.0% |
| Operating profit (loss) | 9901 | €78,075 | €91,765 | +€13,689 | +17.5% |
| Financial charges | 65/66B | €87 | €186 | +€100 | +115% |
| Recurring financial charges | 65 | €87 | €186 | +€100 | +115% |
| Profit (loss) for the period before taxes | 9903 | €77,989 | €91,578 | +€13,590 | +17.4% |
| Income taxes | 67/77 | €18,063 | €20,624 | +€2,562 | +14.2% |
| Profit (loss) for the period | 9904 | €59,926 | €70,954 | +€11,028 | +18.4% |
| Profit (loss) for the period to be appropriated | 9905 | €59,926 | €70,954 | +€11,028 | +18.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.